TF and cancer: Of the seven cancer types that had more than one known driver TF specific to them, three cancers (BRCA, OV, and SKCM) showed a significant (alpha = 0.05) enrichment between InPheRNo-identified TFs and known cancer type-specific drivers, with an overall combined p value (Fisher’s method) of p = 2.5E-4 (Fig. 3b).